Ambu's Ascope Gastro and Abox 2 approved by FDA

Two new products can be sent to the US market after Ambu has received the green light from the US health authorities.

Photo: Ambu / PR

Ambu has been granted regulatory clearance from the US Food and Drug Administration for its single-use endoscope, Ascope Gastro, and the display unit, Abox 2, the company announces in a press release on Friday.

Ascope Gastro is the first sterile single-use gastroscope, and it includes advanced imaging and design features combined with next-generation display and processor technology, according to Ambu.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs